Building Cell Selectivity into CPP-Mediated Strategies

Irene Martín1, Meritxell Teixidó2, Ernest Giralt3,4

  • 1Institute for Research in Biomedicine (IRB Barcelona), Barcelona Science Park, Baldiri Reixac 10, Barcelona, Spain. irene.martin@irbbarcelona.org.

Insights

Cell-penetrating peptides (CPPs) offer a solution for delivering potent therapeutic molecules intracellularly. This review explores CPP-based strategies for targeted drug delivery to improve cancer therapies.

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Pharmacology

Background:

  • Developing effective and selective therapies for diseases like cancer remains a significant challenge.
  • Many potent therapeutic molecules fail clinical trials due to poor delivery, low specificity, or inability to cross cell membranes.

Approach:

  • Cell-penetrating peptides (CPPs) are explored as a method to facilitate the intracellular delivery of cell-impermeable compounds.
  • Research focuses on designing drug delivery systems that utilize CPPs for targeted transport into specific cells.
  • Strategies involve modifying CPPs or integrating them into sophisticated delivery systems to enhance targeting and efficacy.

Key Points:

  • CPPs can overcome the plasma membrane barrier, enabling intracellular access for therapeutic agents.
  • Some CPPs exhibit inherent cell type specificity, while others require modifications for targeted delivery.
  • The integration of CPPs into advanced drug delivery systems is a key area of research.

Conclusions:

  • CPPs represent a promising strategy for enhancing the delivery and specificity of novel therapeutics.
  • Further development of CPP-based systems could overcome current limitations in drug delivery, leading to more effective treatments.